The FDA has approved a new treatment for patients with a common form of breast cancer that has spread to other parts of the body or cannot be surgically removed.
New data from the American Cancer Society reveals an alarming trend: younger women are increasingly being diagnosed with breast cancer, prompting calls for earlier screenings.